WeRide Inc. — Earnings Release 2003

Mar 28, 2003

Listed Company Information

FE PHARMA TECH<00399> - Results Announcement Far East Pharmaceutical Technology Co., Limited announced on 28/03/2003: (stock code: 00399 ) Year end date: 30/06/2003 Currency: HKD Auditors' Report: N/A Review of Interim Report by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 1/7/2002 from 1/7/2001 to 31/12/2002 to 31/12/2001 Note ('000 ) ('000 ) Turnover : 458,656 282,338 Profit/(Loss) from Operations : 121,691 64,498 Finance cost : N/A (105) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A (131) Profit/(Loss) after Tax & MI : 87,665 54,582 % Change over Last Period : +60.61 % EPS/(LPS)-Basic (in dollars) : 0.172 0.153 -Diluted (in dollars) : 0.168 0.141 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 87,665 54,582 Interim Dividend : Nil Nil per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: The calculation of basic and diluted earnings per share (EPS) of the current period is based on the following data: Six months ended 31 December 2002 HK$'000 (Unaudited) Earnings: Profit attributable to shareholders and earnings for the purposes of basic and diluted EPS 87,665 ========= Six months ended 31 December 2002 (Unaudited) Number of shares: Weighted average number of shares for the purposes of basic EPS 508,932,000 Effect of dilutive potential shares: Share options 14,045,407 -------------- Weighted average number of shares for the purposes of diluted EPS 522,977,407 ============== The computation of diluted earnings per share for the period ended 31 December 2002 does not assume the conversion of the Company's outstanding warrants since its exercise would result in an increase in EPS of the period.